AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma

RecruitingNAAges 18 Years - anyAllCapital Health System, Inc
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The hypothesize that SBRT will limit or reverse tumor growth and thereby convert the borderline resectable disease or locally advanced disease in to a resectable tumor. Furthermore, we want to assess whether SBRT leads to an improved quality of life compared to IMRT.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Able to sign the informed consent and understand the consenting process * Completed neoadjuvant chemotherapy regimen * Patient is 18 years of age and older * Eastern Cooperative Oncology Group (ECOG) Status of 0-1. * Patient has a diagnosis of Stage I to Stage III pancreatic cancer cytologically or pathologically confirmed per American Joint Committee on Cancer (AJCC) staging criteria and NCCN guidelines, based on radiographic imaging or exploratory laparoscopic surgery, low degree of arterial involvement (CA, CHA, SMA) and no aorta involvement. * Patients who are deemed eligible for IMRT or SBRT and approved to receive radiation therapy by multidisciplinary tumor board * Patient shows no evidence of disease progression to distant metastasis based on NCCN. * Negative pregnancy test Exclusion Criteria: * Pregnant or lactating female patients of reproductive potential who are not willing to employ highly effective birth control from screening to 6 months after the last dose of radiation therapy. * Resectable pancreatic cancer (See addendum, NCCN Guidelines 2021, PANC-2) * Unresectable pancreatic cancer (See addendum, NCCN Guidelines 2021, PANC-6) * Patients who are unable to tolerate general anesthetic with full skeletal muscle blockade. * Patients with implanted cardiac pacemakers, defibrillators, electronic devices or implanted devices with metal parts in the thoracic cavity. * Life expectancy of \< 1 year
๐Ÿ’Š

What it tests

  • Cyberknife
๐Ÿ“

Where

1 site
Capital Health Medical Center-Hopewell
Pennington, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy